|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 20, 2017 ) According to Publisher, the Global Radiotherapy Device market is accounted for $5.5 billion in 2015 and is expected to reach $9.1 billion by 2022 growing at a CAGR of 7.4% from 2015 to 2022. Radiotherapy being a painless treatment, increase in cancer patients and sophisticated diagnostic techniques are accelerating the market growth. The multiple side-effects of radiation therapy and shortage of trained personnel could hamper radiotherapy devices market growth. However, challenges in visualizing tumours will limit the radiotherapy device market growth.
External beam therapy is accounted for maximum share of the global radiotherapy market, followed by internal radiotherapy devices and systemic radiotherapy due to a high installation contracts for the Proton Therapy Device Segment. The prostate cancer application segment is expected to witness largest share in both external and internal radiotherapy market. North America is the largest market for radiotherapy devices followed by Europe. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and favourable government activities.
For more information @ http://www.reportsweb.com/radiotherapy-device-global-market-outlook-2016-2022
Some of the key players in global Radiotherapy Device market are Accuray Incorporated, Coviden Plc., IBA Group, GE Healthcare, Elekta AB, IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc, Mitsubishi Electric Corporation, Protom International Inc, Siemens Healthcare, C.R. BARD, Inc.
Angiodynamics Inc, Toshiba Medical Systems Corporation, Shenzhen GeneMDx Biotech. Co., Ltd., Varian Medical Systems, Inc., IntraOp Medical, Inc, Theragenics Corporation, Vision RT Ltd, Koninklijke Philips N.V, Eckert & Ziegler BEBIG, Oncura, Inc. and Sirtex Medical Ltd.
Products Covered:
- Internal Beam Radiotherapy
o Cesium-131
o Iodine-125
o Palladium-103
o Iridium-192
o Electronic Brachytherapy
o Applicators & Afterloaders
- External Beam Radiation Therapy
o Intensity Modulated Radiotherapy (IMRT)
o Stereotactic Technology
o Proton Beam Therapy
o Image-Guided Radiotherapy (IGRT)
o 3D Conformal Radiotherapy (3D CRT)
o Tomotherapy
o Volumetric Modulated Arc Therapy (VMAT)
o Adaptive Radiation Therapy (ART)
o High-energy Linear Accelerators (LINACs)
o Gamma Knife
o CyberKnife
o Other External Therapy
- Systemic Radiation Therapy
o Iobenguane (I-131)
o Rhenium (Re-186)
o Samarium (Sm-153)
o Yttrium-90 (Y-90)
End Users Covered:
- Security and Access Control Clinics
- Ambulatory Surgical Centres
- Hospitals
Applications Covered:
- Brain cancer and Neurosurgery
- Gynecological Cancer
- Penile Cancer
- Esophageal Cancer
- Cervical Cancer
- Breast Cancer
- Prostate Cancer
- Spine Cancer
- Lung and pleura Cancers
- Colorectal Cancer
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564880/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Accuray Incorporated
10.2 Coviden Plc.
10.3 IBA Group
10.4 GE Healthcare
10.5 Elekta AB
10.6 IsoRay Medical, Inc.
10.7 Nordion, Inc.
10.8 RaySearch Laboratories AB
10.9 Mevion Medical Systems, Inc
10.10 Mitsubishi Electric Corporation
10.11 Protom International Inc
10.12 Siemens Healthcare
10.13 C.R. BARD, Inc.
10.14 Angiodynamics Inc
10.15 Toshiba Medical Systems Corporation
10.16 Shenzhen GeneMDx Biotech. Co., Ltd.
10.17 Varian Medical Systems, Inc.
10.18 IntraOp Medical, Inc
10.11 Theragenics Corporation
10.20 Vision RT Ltd
10.21 Koninklijke Philips N.V
10.22 Eckert & Ziegler BEBIG
10.23 Oncura, Inc.
10.24 Sirtex Medical Ltd
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564880/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
